Here’s a new site that I’ve been working on that takes you straight to company development pipelines without having to figure out where they are hiding. Not so much of a problem for small companies I know - but with the larger companies it’s not always obvious where the development pipeline is located
PharmaCompanyPipelines.com
Please let me know if you have other suggestions or find broken links (email is at the bottom of the page.
I’ll be making it a little more functional shortly - but currently I am dealing with some hosting issues
More interesting websites to come soon….keep tuned in
Categories: Biotechnology · Competitor · Competitors · Pharma companies · Pharmaceutical
Attached are some highlights from an analysis of Biotechnology drugs that I recently carried out. It is an analysis of recombinant therapies only. I’ll probably have some more info to add to this over the next week or so as I delve deeper in to the data I collected.
Recombinant Drug Approvals
Categories: Biotechnology · FDA · Industry data · Regulatory · Statistics · US
Bio-reagent manufacturers have, for a long time, held the tradition of creating beautiful diagrams of cell signalling pathways and biological systems. These are a few sites that I tend to go to when learning about new signalling systems:
Cell Signaling
R&D Systems
EMD Biosciences
E Biosciences
Sigma Aldrich
(Image from Cell Signaling Website)
Categories: Biomedical · Biotechnology · Images · Reference
Probably a fairly well known reference to many of you - the OMIM database is a database of diseases with a genetic component. It is maintained by Johns Hopkins University. Its a good place to look up information on diseases and to also find synonyms of disease names.
It can be searched via this webpage
Categories: Biotechnology · Database · Genetics · Reference
Here’s an interesting article by the Tuft’s Center for the Study of Drug Development.
http://csdd.tufts.edu/NewsEvents/RecentNews.asp?newsid=67
It summarizes research showing that the faster you can get a drug to the market the more successful you will be. The article includes some data on top performers (Bayer, Astra-Zeneca, Allergan, Boehringer Ingelheim, and Merck) and discontinuation statistics.
Categories: Biotechnology · Industry data · Pharmaceutical
